Editor Profile
Dr. B. Adriana Gutierrez Grebenkova, M.D., Ph.D.
Postdoctoral Fellow
Present
The University of Texas Medical Branch (UTMB)
Texas
United States
Dr. Berenice Adriana Gutierrez Grebenkova is a Postdoctoral Fellow at The University of Texas Medical Branch specializing in Alzheimer's disease and synaptic dysfunction. With dual MD-PhD training, she brings a unique clinical-research perspective to investigating cognitive resilience in neurodegenerative diseases. Her research has focused on synaptic receptor dysfunction, electrophysiology using human synapse microtransplantation, and molecular mechanisms underlying Alzheimer's progression. She has published in high-impact journals including Acta Neuropathologica and Journal of Biological Chemistry, and has served as a peer reviewer for Cellular and Molecular Neurobiology, BMC Neurology, and Brain Communications. Her research has been presented at major scientific conferences including the Society for Neuroscience and Alzheimer's Association International Conference. Dr. Gutierrez is committed to advancing translational neuroscience through interdisciplinary collaboration to develop novel therapeutic approaches for Alzheimer's disease.
- Alzheimer's disease pathophysiology and cognitive resilience mechanisms
- Synaptic receptor dysfunction in neurodegenerative diseases
- AMPA and GABA receptor characterization and calcium-permeable receptor analysis
- Human synapse microtransplantation and electrophysiology techniques
- Molecular mechanisms underlying Alzheimer's disease progression
- Mitochondrial bioenergetics in neurodegeneration
- Translational neuroscience bridging molecular research with clinical neuropathology
- Neuroprotective mechanisms and therapeutic target identification
- Single-cell RNA sequencing analysis in brain tissue
- Excitatory-inhibitory synaptic balance in cognitive function
- Ma et al. (2025). Evidence for cPLA2 activation in Alzheimer's Disease Synaptic Pathology. PMID: 40236242.
- Baumgartner TJ, Silva-Pérez M, Haghighijoo Z, et al. (2025). Inhibition of the GSK3β/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitability. Alzheimers Dement. PMID: 40717647.
- Scaduto et al. (2022). Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer's disease neuropathologic change. Acta Neuropathologica. PMID: 36538112.
- Gutierrez BA and Limon A. (2022). Synaptic disruption by soluble oligomers in patients with Alzheimer's and Parkinson's disease. Biomedicines. PMID: 35885050.
